---
title: "Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293669374.md"
description: "Charles River Laboratories International Inc. (CRL) shares rose 4.84% to $229.29, outperforming competitors like Labcorp and Alnylam during a broader market decline. This gain ended a four-day losing streak, though the stock remains below its 52-week high. Trading volume exceeded the 50-day average."
datetime: "2026-07-23T21:16:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293669374.md)
  - [en](https://longbridge.com/en/news/293669374.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293669374.md)
---

# Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. (CRL) rose 4.84% to $229.29 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.

The stock's rise snapped a four-day losing streak.

Charles River Laboratories International Inc. closed 3.60% below its 52-week high of $237.86, which the company achieved on July 10th.

The stock outperformed some of its competitors Thursday, as Labcorp Holdings Inc. (LH) rose 3.40% to $291.02, Alnylam Pharmaceuticals Inc. (ALNY) rose 0.66% to $268.74, and Bio-Techne Corp. (TECH) fell 0.01% to $71.77.

Trading volume (1.1 M) eclipsed its 50-day average volume of 888,225.

Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-23-26 1716ET

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [LH.US](https://longbridge.com/en/quote/LH.US.md)
- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)
- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Amundi Increases Stake in Charles River Laboratories International, Inc. $CRL](https://longbridge.com/en/news/294574425.md)
- [Charles River Laboratories Earnings Preview: What to Expect](https://longbridge.com/en/news/293235736.md)
- [Stocks Supported by Easing Middle East Tensions](https://longbridge.com/en/news/294707679.md)
- [Charles River Laboratories International (CRL) Expands AI Pathology Platform, Is The Valuation Upside Already Priced In?](https://longbridge.com/en/news/292410138.md)
- [Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To Competitors](https://longbridge.com/en/news/288906897.md)